Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-COV-2 Variants: Differences and Potential of Immune Evasion.

Frontiers in cellular and infection microbiology - 1 Jan 2021

Hirabara Sandro M, Serdan Tamires D A, Gorjao Renata, Masi Laureane N, Pithon-Curi Tania C, Covas Dimas T, Curi Rui, Durigon Edison L

Abstract excerpt

The structural spike (S) glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) plays an essential role in infection and is an important target for neutralizing antibody recognition. Mutations in the S gene can generate variants of concern (VOCs), which improve "viral fitness" through selective or survival advantages, such as increased ACE-2 receptor affinity, infectivity, viral replication,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to COVID-19

Share to Immune Evasion

Share to Mutation

Share to Pandemics

Share to SARS-CoV-2 and COVID-19 Research

Source

Open in PubMed Open full text

Identifiers

PMID: 35118007
DOI: 10.3389/fcimb.2021.781429
PMCID: PMC8805732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-COV-2 Variants: Differences and Potential of Immune Evasion.PMID 35118007Read ↗

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read ↗

Novel SARS-CoV-2 variants: the pandemics within the pandemic.Semantic proximity Read ↗

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Semantic proximity Read ↗

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections.Semantic proximity Read ↗

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance.Semantic proximity Read ↗

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesSemantic proximity Read ↗

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity.Semantic proximity Read ↗

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read ↗

SARS-CoV-2 variants: A double-edged sword?Semantic proximity Read ↗

Mutations of SARS-CoV-2 and their impact on disease diagnosis and severitySemantic proximity Read ↗

Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activitySemantic proximity Read ↗

SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.